0.3991
전일 마감가:
$0.4179
열려 있는:
$0.417
하루 거래량:
638.56K
Relative Volume:
0.27
시가총액:
$36.70M
수익:
$1.22M
순이익/손실:
$-14.15M
주가수익비율:
-1.535
EPS:
-0.26
순현금흐름:
$-6.55M
1주 성능:
-1.63%
1개월 성능:
-2.97%
6개월 성능:
+48.36%
1년 성능:
+7.89%
IGC Pharma Inc Stock (IGC) Company Profile
명칭
IGC Pharma Inc
전화
301-983-0998
주소
4336 Montgomery Avenue, Bethesda, MD
IGC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IGC
IGC Pharma Inc
|
0.3991 | 38.43M | 1.22M | -14.15M | -6.55M | -0.26 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
IGC Pharma Inc 주식(IGC)의 최신 뉴스
Will IGC Pharma Inc. stock gain from government policies2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Short interest data insights for IGC Pharma Inc.Market Risk Analysis & Accurate Entry and Exit Point Alerts - newser.com
What downside risks could hit IGC Pharma Inc. stockWeekly Trade Review & Fast Moving Stock Trade Plans - newser.com
Applying Wyckoff theory to IGC Pharma Inc. stockMarket Trend Report & Reliable Price Breakout Alerts - newser.com
Candlestick signals on IGC Pharma Inc. stock todayJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders - Lelezard
600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors - Stock Titan
What to expect from IGC Pharma Inc. in the next 30 daysTrade Exit Summary & High Accuracy Trade Alerts - newser.com
Developing predictive dashboards with IGC Pharma Inc. dataJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - newser.com
Will IGC Pharma Inc. stock profit from AI boom2025 Market Trends & Technical Buy Zone Confirmation - newser.com
IGC Pharma Subsidiary Signs Asset Sale Agreement - MSN
What candlestick patterns are forming on IGC Pharma Inc.Portfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
How IGC Pharma Inc. stock reacts to monetary easingJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com
IGC's Latest Discovery in Alzheimer's Treatment Shows Promise - GuruFocus
IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease - ACCESS Newswire
Kd 3.95 μM: IGC Pharma's IGC-1C Modulates Tau LLPS, Inhibits and Dissolves Condensates - Stock Titan
Will IGC Pharma Inc. (IGS1) stock rise with strong economy2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
IGC Pharma, Inc. (NYSEAMERICAN:IGC) Sees Significant Decline in Short Interest - Defense World
Is IGC Pharma Inc. (IGS1) stock inflation resilient2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Real time scanner hits for IGC Pharma Inc. explained2025 Market Overview & Weekly High Potential Stock Alerts - newser.com
Is IGC Pharma Inc. stock a buy in volatile marketsLong Setup & Weekly Top Gainers Alerts - newser.com
How IGC Pharma Inc. stock benefits from global expansionEarnings Summary Report & Weekly Market Pulse Updates - newser.com
Is IGC Pharma Inc. stock a contrarian buy2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com
Can IGC Pharma Inc. hit a new high this monthMarket Rally & Weekly Market Pulse Updates - newser.com
How institutional ownership impacts IGC Pharma Inc. stockMarket Trend Review & Verified Technical Signals - newser.com
Institutional scanner results for IGC Pharma Inc.2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Can IGC Pharma Inc. stock attract ESG capital inflowsJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
What analysts say about IGC Pharma Inc IGS1 stockMid Cap Growth Trends & Low Risk Portfolio Growth - earlytimes.in
IGC Pharma subsidiary agrees to asset sale valued at $2.7 million - Investing.com Nigeria
IGC Pharma Inc (IGC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):